Bank of America Corp
Change company Symbol lookup
Select an option...
BML-G Bank of America Corp
AROC Archrock Inc
HBAN Huntington Bancshares Inc
MRNA Moderna Inc
TCOM Trip.com Group Ltd
XCOMQ Xtera Communications Inc
IBM International Business Machines Corp
MQ Marqeta Inc
K Kellogg Co
VTI Vanguard Total Stock Market Index Fund ETF Shares
Go

Financials : Banks | Large Cap Value
Company profile

Bank of America Corporation is a bank holding company and a financial holding company. The Company is a financial institution, serving individual consumers, small- and middle-market businesses, institutional investors, corporations and governments with a range of banking, investing, asset management and other financial and risk management products and services. The Company, through its banking and various non-bank subsidiaries, throughout the United States and in international markets, provides a range of banking and non-bank financial services and products through four business segments: Consumer Banking, which comprises Deposits and Consumer Lending; Global Wealth & Investment Management, which consists of two primary businesses: Merrill Lynch Global Wealth Management and Bank of America Private Bank; Global Banking, which provides a range of lending-related products and services; Global Markets, which offers sales and trading services and research services.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$23.56
Day's Change
0.1699 (0.73%)
Bid
--
Ask
--
B/A Size
--
Day's High
23.57
Day's Low
23.33
Volume
(Heavy Day)
Volume:
11,123

10-day average volume:
5,714
11,123

MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

7:41 am ET October 29, 2021 (Accesswire) Print

LOS ANGELES, CA / ACCESSWIRE / October 29, 2021/ The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. ("Spectrum" or "the Company") (NASDAQ:SPPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Image: https://www.accesswire.com/users/newswire/images/670323/image.png

Investors who purchased the Company's securities between December 27, 2018 and August 5, 2021, inclusive (the ''Class Period''), are encouraged to contact the firm before November 1, 2021.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Spectrum's manufacturing facility for ROLONTIS failed to maintain appropriate controls and procedures. These deficiencies diminished the likelihood of the Company's Biologics License Application (BLA) for ROLONTIS receiving FDA approval. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Spectrum, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm

Brian Schall, Esq.,

www.schallfirm.com

Office: 310-301-3335

info@schallfirm.com

SOURCE: The Schall Law Firm

View source version on accesswire.com:

https://www.accesswire.com/670323/MONDAY-DEADLINE-ALERT-The-Schall-Law-Firm-Reminds-Investors-of-a-Class-Action-Lawsuit-Against-Spectrum-Pharmaceuticals-Inc-and-Encourages-Investors-with-Losses-in-Excess-of-100000-to-Contact-the-Firm

comtex tracking

COMTEX_396035545/2457/2021-10-29T07:41:02

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.